\-\ Texto\\:\\ \ \(0\)\
\-\ cv\\:\\ rrr\\ with\\ out\\ r\\/g\\/m\ \(0\)\
\-\ pulm\\:\\ ctab\\ w\\/o\\ r\\/r\\/w\ \(0\)\
\-\ the\\ treatment\\ for\\ mac\\ is\\ currently\\ debated\\,\\ but\\ it\\ tends\\ to\\ somewhat\\ mirror\\ tb\\ treatment\\.4\\,5\\ the\\ pt\\ was\\ started\\ on\\ clarithromycin\\ 500mg\\ po\\ bid\\ with\\ ethambutol\\ 20mg\\/kg\\ qday\\,\\ rifampin\\ 600mg\\ qday\\ for\\ 12\\ months\\ until\\ culture\\ negative\\.4\\,5\\ streptomycin\\ 1g\\ 3\\-5\\ days\\ qwek\\ for\\ 6\\-12\\ weeks\\ is\\ specifically\\ for\\ treatment\\ of\\ the\\ cavitation\\.5\ \(0\)\
\-\ ct\\ \\(09\\-dec\\-2008\\)\ \(0\)\
\-\ 1\\.\\ no\\ pe\\ or\\ dvt\\.\\ \ \(0\)\
\-\ 2\\.\\ consolidation\\ of\\ the\\ apical\\ posterior\\ segment\\ of\\ the\\ right\\ upper\\ lobe\\ \\ consistent\\ with\\ pneumonia\\.\\ \ \(0\)\
\-\ 3\\.\\ diffuse\\ interstitial\\ disease\\,\\ pulmonary\\ fibrosis\\ and\\ traction\\ \\ bronchiectasis\\ consistent\\ with\\ history\\ of\\ sarcoidosis\\.\ \(0\)\
\-\ chest\\ pa\\/lat\\ \\(09\\-dec\\-2008\\)\\:\ \(0\)\
\-\ 1\\.\\ diminished\\ right\\ lower\\ lobe\\ infiltrative\\ process\\.\ \(0\)\
\-\ 2\\.\\ diffuse\\ bilateral\\ interstitial\\ lung\\ disease\\,\\ not\\ appreciably\\ changed\\.\\ \\ \\ \ \(0\)\
\-\ 3\\.\\ persistent\\ right\\ apical\\ pleural\\ thickening\\.\ \(0\)\
\-\ ct\\ \\(06\\-apr\\-2009\\)\ \(0\)\
\-\ 1\\.\\ increased\\ right\\ middle\\ lobe\\ consolidation\\ with\\ a\\ 2\\.4\\ cm\\ cavitation\\.\ \(0\)\
\-\ 2\\.\\ nearly\\ resolved\\ right\\ upper\\ lobe\\ consolidation\\.\\ \\ \\ \ \(0\)\
\-\ 3\\.\\ traction\\ bronchiectasis\\ and\\ fibrosis\\ as\\ described\\ as\\ can\\ be\\ seen\\ with\\ sarcoidosis\\.\\ \\ \\ \ \(0\)\
\-\ 4\\.\\ at\\ the\\ lung\\ bases\\,\\ there\\ are\\ fibrotic\\ and\\ emphysematous\\ like\\ changes\\.\\ \\ \\ \ \(0\)\
\-\ 5\\.\\ stable\\ mild\\ mediastinal\\ lymphadenopathy\\.\ \(0\)\
\-\ mycobacterial\\ avium\\ complex\\ pulmonary\\ infection\ \(0\)\
\-\ \\â\\€\\¢\\ sacoidosis\\ exacerbation\ \(0\)\
\-\ \\â\\€\\¢\\ tb\ \(0\)\
\-\ \\â\\€\\¢\\ ntm\ \(0\)\
\-\ \\â\\€\\¢\\ pulmonary\\ scc\ \(0\)\
\-\ \\â\\€\\¢\\ fungal\\ infection\ \(1\)\
\-\ patient\\ is\\ a\\ 49\\ y\\/o\\ ad\\ usn\\ male\\ with\\ history\\ of\\ sarcoidosis\\ presented\\ to\\ his\\ pcm\\ in\\ early\\ december\\ with\\ a\\ 4\\ day\\ history\\ of\\ dyspnea\\ and\\ myalgias\\.\\ he\\ was\\ originally\\ seen\\ by\\ a\\ civilian\\ provider\\ and\\ was\\ given\\ azitrhomycin\\ 250mg\\ which\\ had\\ no\\ effect\\ on\\ his\\ condition\\.\\ upon\\ admission\\ he\\ noted\\ fatigue\\,\\ cough\\ and\\ pleuritic\\ chest\\ pain\\.\\ his\\ pulse\\ oximetry\\ was\\ 88\\%\\ while\\ walking\\,\\ whereas\\ his\\ normal\\ baseline\\ is\\ 95\\%\\.\\ his\\ home\\ medications\\ include\\ advair\\ and\\ spiriva\\.\\ pt\\ was\\ admitted\\ to\\ hospital\\ for\\ sarcoid\\ exacerbation\\ with\\ an\\ elevated\\ wbc\\ of\\ 11\\.3\\.\\ he\\ was\\ started\\ on\\ prednisone\\ taper\\ and\\ levofloxacin\\ 750mg\\ qday\\ for\\ 21\\ days\\.\\ a\\ chest\\ posterior\\-anterior\\ and\\ lateral\\ x\\-ray\\ showed\\ rml\\ and\\ rul\\ opacity\\ consistent\\ with\\ infection\\.\\ a\\ ct\\,\\ pe\\ protocol\\ 1\\.25\\ mm\\ contiguous\\ axial\\ images\\ with\\ iv\\ contrast\\ was\\ performed\\ which\\ showed\\ consolidation\\ of\\ the\\ apical\\ posterior\\ segment\\ of\\ the\\ right\\ upper\\ lobe\\ consistent\\ with\\ pneumonia\\.\\ the\\ patient\\ was\\ discharged\\ from\\ the\\ hospital\\.\\ he\\ returned\\ to\\ his\\ pcm\\ intermittently\\ with\\ very\\ little\\ improvement\\.\\ in\\ april\\ he\\ returned\\ to\\ his\\ pcm\\ with\\ thick\\ green\\ sputum\\,\\ fevers\\ of\\ 102\\.9\\ and\\ nightsweats\\ while\\ on\\ levofloxacin\\.\\ a\\ sputum\\ sample\\ was\\ taken\\ which\\ showed\\ candida\\ albicans\\ and\\ afb\\.\\ the\\ patient\\ was\\ isolated\\ for\\ tb\\ at\\ that\\ time\\,\\ and\\ the\\ reflexive\\ pcr\\ showed\\ the\\ afb\\ to\\ be\\ mycobacterium\\ avium\\ complex\\ \\(mac\\)\\ which\\ is\\ a\\ nontuberculous\\ mycobacteria\\ \\(ntm\\)\\.\\ a\\ chest\\ ct\\ without\\ contrast\\,\\ 5\\ mm\\ thick\\ axial\\ slices\\,\\ was\\ obtained\\ which\\ showed\\ increased\\ right\\ middle\\ lobe\\ consolidation\\ with\\ a\\ 2\\.4\\ cm\\ cavitation\\ and\\ nearly\\ resolved\\ right\\ upper\\ lobe\\ consolidation\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ consolidation\\:\\ 0\\.23775002318190885\ \(0\)\
\-\ qday\\:\\ 0\\.1900552049876204\ \(0\)\
\-\ his\\:\\ 0\\.1820044771086692\ \(0\)\
\-\ lobe\\:\\ 0\\.17342710042690387\ \(0\)\
\-\ pcm\\:\\ 0\\.16724686196329938\ \(0\)\
\-\ was\\:\\ 0\\.16435324888465452\ \(0\)\
\-\ cavitation\\:\\ 0\\.16180943416659666\ \(0\)\
\-\ showed\\:\\ 0\\.1427778464292582\ \(0\)\
\-\ apical\\:\\ 0\\.13222385656789049\ \(0\)\
\-\ ntm\\:\\ 0\\.13102767288946918\ \(0\)\
\-\ levofloxacin\\:\\ 0\\.13102767288946918\ \(0\)\
\-\ he\\:\\ 0\\.12693518286015606\ \(0\)\
\-\ with\\:\\ 0\\.12592215969694187\ \(0\)\
\-\ and\\:\\ 0\\.1240247051134024\ \(0\)\
\-\ mac\\:\\ 0\\.12334935764481694\ \(0\)\
\-\ avium\\:\\ 0\\.12334935764481694\ \(0\)\
\-\ tb\\:\\ 0\\.1145256551038036\ \(0\)\
\-\ right\\:\\ 0\\.11370988247839818\ \(0\)\
\-\ the\\:\\ 0\\.1112078932015139\ \(0\)\
\-\ sarcoidosis\\:\\ 0\\.1089473974936955\ \(0\)\
\-\ afb\\:\\ 0\\.10409540205720919\ \(0\)\
\-\ which\\:\\ 0\\.09747089407875649\ \(0\)\
\-\ sputum\\:\\ 0\\.0959242168688077\ \(0\)\
\-\ exacerbation\\:\\ 0\\.09410001918747367\ \(0\)\
\-\ consistent\\:\\ 0\\.09298403320229469\ \(0\)\
\-\ upper\\:\\ 0\\.09163984438108895\ \(0\)\
\-\ for\\:\\ 0\\.09095853731561188\ \(0\)\
\-\ traction\\:\\ 0\\.09066025882221143\ \(0\)\
\-\ chest\\:\\ 0\\.09051937780483851\ \(0\)\
\-\ bronchiectasis\\:\\ 0\\.08966883230396369\ \(0\)\
\-\ nearly\\:\\ 0\\.08550539229214696\ \(0\)\
\-\ of\\:\\ 0\\.08389797744309745\ \(0\)\
\-\ thick\\:\\ 0\\.08148733412267144\ \(0\)\
\-\ returned\\:\\ 0\\.08058699398264951\ \(0\)\
\-\ pulmonary\\:\\ 0\\.07839679364923258\ \(0\)\
\-\ interstitial\\:\\ 0\\.07773041313526625\ \(0\)\
\-\ infection\\:\\ 0\\.0776909237637133\ \(0\)\
\-\ resolved\\:\\ 0\\.0770245939627126\ \(0\)\
\-\ started\\:\\ 0\\.07222532531230542\ \(0\)\
\-\ fibrosis\\:\\ 0\\.07182974494152891\ \(0\)\
\-\ pe\\:\\ 0\\.07088407549529405\ \(0\)\
\-\ segment\\:\\ 0\\.07079270021968218\ \(0\)\
\-\ streptomycin\\:\\ 0\\.06856114728420384\ \(0\)\
\-\ qwek\\:\\ 0\\.06856114728420384\ \(0\)\
\-\ sacoidosis\\:\\ 0\\.06856114728420384\ \(0\)\
\-\ azitrhomycin\\:\\ 0\\.06856114728420384\ \(0\)\
\-\ 750mg\\:\\ 0\\.06856114728420384\ \(0\)\
\-\ reflexive\\:\\ 0\\.06856114728420384\ \(0\)\
\-\ nontuberculous\\:\\ 0\\.06856114728420384\ \(0\)\
\-\ pneumonia\\:\\ 0\\.06767732890273923\ \(0\)\
\-\ posterior\\:\\ 0\\.0665079443637744\ \(0\)\
\-\ complex\\:\\ 0\\.06606404637757178\ \(0\)\
\-\ 1g\\:\\ 0\\.06551383644473459\ \(0\)\
\-\ appreciably\\:\\ 0\\.06551383644473459\ \(0\)\
\-\ spiriva\\:\\ 0\\.06551383644473459\ \(0\)\
\-\ ct\\:\\ 0\\.06528660223780351\ \(0\)\
\-\ to\\:\\ 0\\.06430701263330761\ \(0\)\
\-\ clarithromycin\\:\\ 0\\.06335173499587347\ \(0\)\
\-\ ethambutol\\:\\ 0\\.06335173499587347\ \(0\)\
\-\ 250mg\\:\\ 0\\.06335173499587347\ \(0\)\
\-\ nightsweats\\:\\ 0\\.06335173499587347\ \(0\)\
\-\ hospital\\:\\ 0\\.06333462608077566\ \(0\)\
\-\ pt\\:\\ 0\\.06170662537450998\ \(0\)\
\-\ mm\\:\\ 0\\.061362196864997665\ \(0\)\
\-\ middle\\:\\ 0\\.061313630791895446\ \(0\)\
\-\ treatment\\:\\ 0\\.061266166093627714\ \(0\)\
\-\ debated\\:\\ 0\\.060304424156404225\ \(0\)\
\-\ advair\\:\\ 0\\.060304424156404225\ \(0\)\
\-\ albicans\\:\\ 0\\.060304424156404225\ \(0\)\
\-\ 500mg\\:\\ 0\\.05914589034386259\ \(0\)\
\-\ rifampin\\:\\ 0\\.05914589034386259\ \(0\)\
\-\ 600mg\\:\\ 0\\.05914589034386259\ \(0\)\
\-\ civilian\\:\\ 0\\.05914589034386259\ \(0\)\
\-\ mycobacteria\\:\\ 0\\.05914589034386259\ \(0\)\
\-\ is\\:\\ 0\\.058703502285075065\ \(0\)\
\-\ 12\\:\\ 0\\.058613582282564344\ \(0\)\
\-\ taper\\:\\ 0\\.05814232270754311\ \(0\)\
\-\ slices\\:\\ 0\\.05814232270754311\ \(0\)\
\-\ usn\\:\\ 0\\.05725711331693497\ \(0\)\
\-\ myalgias\\:\\ 0\\.05725711331693497\ \(0\)\
\-\ intermittently\\:\\ 0\\.05725711331693497\ \(0\)\
\-\ oximetry\\:\\ 0\\.056465266534078094\ \(0\)\
\-\ while\\:\\ 0\\.05541422207166411\ \(0\)\
\-\ mycobacterium\\:\\ 0\\.055095011868073855\ \(0\)\
\-\ rml\\:\\ 0\\.05449344343262424\ \(0\)\
\-\ sample\\:\\ 0\\.05449344343262424\ \(0\)\
\-\ candida\\:\\ 0\\.05449344343262424\ \(0\)\
\-\ pcr\\:\\ 0\\.05449344343262424\ \(0\)\
\-\ days\\:\\ 0\\.05427925396408291\ \(0\)\
\-\ bid\\:\\ 0\\.053936478055532214\ \(0\)\
\-\ diffuse\\:\\ 0\\.05377169795512177\ \(0\)\
\-\ fibrotic\\:\\ 0\\.052932910419212734\ \(0\)\
\-\ green\\:\\ 0\\.052932910419212734\ \(0\)\
\-\ mirror\\:\\ 0\\.05247728041923093\ \(0\)\
\-\ scc\\:\\ 0\\.05247728041923093\ \(0\)\
\-\ rul\\:\\ 0\\.05247728041923093\ \(0\)\
\-\ april\\:\\ 0\\.05247728041923093\ \(0\)\
\-\ lung\\:\\ 0\\.05215867523561756\ \(0\)\
\-\ december\\:\\ 0\\.05204770102860459\ \(0\)\
\-\ on\\:\\ 0\\.051791931279563976\ \(0\)\
\-\ mycobacterial\\:\\ 0\\.05164135378406453\ \(0\)\
\-\ pleuritic\\:\\ 0\\.05164135378406453\ \(0\)\
\-\ ad\\:\\ 0\\.05088916721606296\ \(0\)\
\-\ tends\\:\\ 0\\.049578798072282715\ \(0\)\
\-\ axial\\:\\ 0\\.04952844656372708\ \(0\)\
\-\ cm\\:\\ 0\\.049243382695309756\ \(0\)\
\-\ history\\:\\ 0\\.049138389301440044\ \(0\)\
\-\ pulm\\:\\ 0\\.049000390189135344\ \(0\)\
\-\ emphysematous\\:\\ 0\\.04820854340627847\ \(0\)\
\-\ changed\\:\\ 0\\.04796210843440385\ \(0\)\
\-\ ctab\\:\\ 0\\.047050009593736834\ \(0\)\
\-\ provider\\:\\ 0\\.04683828874027423\ \(0\)\
\-\ increased\\:\\ 0\\.04636593041444639\ \(0\)\
\-\ whereas\\:\\ 0\\.04550290927965513\ \(0\)\
\-\ baseline\\:\\ 0\\.045330129411105716\ \(0\)\
\-\ prednisone\\:\\ 0\\.04516123256680921\ \(0\)\
\-\ dvt\\:\\ 0\\.044996048043296676\ \(0\)\
\-\ contiguous\\:\\ 0\\.0442205572914313\ \(0\)\
\-\ bases\\:\\ 0\\.0440746188559635\ \(0\)\
\-\ po\\:\\ 0\\.0439314603699538\ \(0\)\
\-\ infiltrative\\:\\ 0\\.0439314603699538\ \(0\)\
\-\ 88\\:\\ 0\\.043790977900804974\ \(0\)\
\-\ originally\\:\\ 0\\.043653073237640706\ \(0\)\
\-\ specifically\\:\\ 0\\.0431254465833274\ \(0\)\
\-\ cv\\:\\ 0\\.04263244408826333\ \(0\)\
\-\ diminished\\:\\ 0\\.042514085842551994\ \(0\)\
\-\ little\\:\\ 0\\.04216980000165547\ \(0\)\
\-\ protocol\\:\\ 0\\.041840597305406464\ \(0\)\
\-\ patient\\:\\ 0\\.04183201453167183\ \(0\)\
\-\ contrast\\:\\ 0\\.041660946611371985\ \(0\)\
\-\ culture\\:\\ 0\\.04152521145289554\ \(0\)\
\-\ fatigue\\:\\ 0\\.04152521145289554\ \(0\)\
\-\ isolated\\:\\ 0\\.04074366706133572\ \(0\)\
\-\ 95\\:\\ 0\\.04065145003597739\ \(0\)\
\-\ 49\\:\\ 0\\.04047034263940222\ \(0\)\
\-\ pulse\\:\\ 0\\.04047034263940222\ \(0\)\
\-\ seen\\:\\ 0\\.04036727832918714\ \(0\)\
\-\ walking\\:\\ 0\\.040293496991324756\ \(0\)\
\-\ sarcoid\\:\\ 0\\.04020661055224162\ \(0\)\
\-\ rrr\\:\\ 0\\.03995182027847885\ \(0\)\
\-\ somewhat\\:\\ 0\\.03901114500310093\ \(0\)\
\-\ fungal\\:\\ 0\\.03837564606634313\ \(0\)\
\-\ home\\:\\ 0\\.03791603429499703\ \(0\)\
\-\ fevers\\:\\ 0\\.0378526111905593\ \(0\)\
\-\ dyspnea\\:\\ 0\\.0377273484029987\ \(0\)\
\-\ improvement\\:\\ 0\\.03742303179993297\ \(0\)\
\-\ opacity\\:\\ 0\\.03730467355422163\ \(0\)\
\-\ discharged\\:\\ 0\\.036793984016596434\ \(0\)\
\-\ disease\\:\\ 0\\.035992015302172164\ \(0\)\
\-\ medications\\:\\ 0\\.03596383416363168\ \(0\)\
\-\ admission\\:\\ 0\\.03576987260454848\ \(0\)\
\-\ until\\:\\ 0\\.03567473724215418\ \(0\)\
\-\ admitted\\:\\ 0\\.03512790752846528\ \(0\)\
\-\ described\\:\\ 0\\.034784277698853096\ \(0\)\
\-\ be\\:\\ 0\\.03478265218891316\ \(0\)\
\-\ lymphadenopathy\\:\\ 0\\.03465936191562223\ \(0\)\
\-\ mediastinal\\:\\ 0\\.034618180479574746\ \(0\)\
\-\ as\\:\\ 0\\.03444614965713904\ \(0\)\
\-\ condition\\:\\ 0\\.03425736271475237\ \(0\)\
\-\ 21\\:\\ 0\\.03425736271475237\ \(0\)\
\-\ taken\\:\\ 0\\.03425736271475237\ \(0\)\
\-\ stable\\:\\ 0\\.03391307687385584\ \(0\)\
\-\ upon\\:\\ 0\\.03372840927196808\ \(0\)\
\-\ persistent\\:\\ 0\\.03303202318878589\ \(0\)\
\-\ currently\\:\\ 0\\.032932915028096005\ \(0\)\
\-\ at\\:\\ 0\\.032386351502134814\ \(0\)\
\-\ pleural\\:\\ 0\\.03227350503382659\ \(0\)\
\-\ process\\:\\ 0\\.03215420739766663\ \(0\)\
\-\ cough\\:\\ 0\\.03200769996547113\ \(0\)\
\-\ like\\:\\ 0\\.03186399399497572\ \(0\)\
\-\ early\\:\\ 0\\.030903250367822342\ \(0\)\
\-\ very\\:\\ 0\\.030754421875301304\ \(0\)\
\-\ iv\\:\\ 0\\.030632610565768915\ \(0\)\
\-\ obtained\\:\\ 0\\.030324842484674975\ \(0\)\
\-\ wbc\\:\\ 0\\.03030168193237273\ \(0\)\
\-\ effect\\:\\ 0\\.03007391925152971\ \(0\)\
\-\ given\\:\\ 0\\.029491357959448607\ \(0\)\
\-\ elevated\\:\\ 0\\.029226194194357336\ \(0\)\
\-\ thickening\\:\\ 0\\.02916630867213334\ \(0\)\
\-\ out\\:\\ 0\\.028180158409250818\ \(0\)\
\-\ no\\:\\ 0\\.027882764115734045\ \(0\)\
\-\ day\\:\\ 0\\.027308523826337954\ \(0\)\
\-\ changes\\:\\ 0\\.025909854785186044\ \(0\)\
\-\ weeks\\:\\ 0\\.025693838079491976\ \(0\)\
\-\ include\\:\\ 0\\.02550825844638238\ \(0\)\
\-\ time\\:\\ 0\\.02541112503263444\ \(0\)\
\-\ performed\\:\\ 0\\.025363025071497142\ \(0\)\
\-\ presented\\:\\ 0\\.02500033463497985\ \(0\)\
\-\ months\\:\\ 0\\.024954785445410042\ \(0\)\
\-\ mild\\:\\ 0\\.024302735707264468\ \(0\)\
\-\ bilateral\\:\\ 0\\.02304082209037237\ \(0\)\
\-\ noted\\:\\ 0\\.02273050122284995\ \(0\)\
\-\ without\\:\\ 0\\.022613198612125147\ \(0\)\
\-\ can\\:\\ 0\\.022497698747501682\ \(0\)\
\-\ it\\:\\ 0\\.021945413067493806\ \(0\)\
\-\ lower\\:\\ 0\\.021907474605940787\ \(0\)\
\-\ had\\:\\ 0\\.021360246556845708\ \(0\)\
\-\ in\\:\\ 0\\.021330164550103628\ \(0\)\
\-\ lateral\\:\\ 0\\.021276272574018477\ \(0\)\
\-\ but\\:\\ 0\\.021200112064128078\ \(0\)\
\-\ images\\:\\ 0\\.019831005605791534\ \(0\)\
\-\ male\\:\\ 0\\.019088120515801887\ \(0\)\
\-\ that\\:\\ 0\\.018604700760748296\ \(0\)\
\-\ by\\:\\ 0\\.018205801182246982\ \(0\)\
\-\ normal\\:\\ 0\\.01750421890886311\ \(0\)\
\-\ there\\:\\ 0\\.017058507866734317\ \(0\)\
\-\ from\\:\\ 0\\.01702681317232054\ \(0\)\
\-\ not\\:\\ 0\\.0169247189037554\ \(0\)\
\-\ an\\:\\ 0\\.01639398599055335\ \(0\)\
\-\ are\\:\\ 0\\.01626785223900702\ \(0\)\
\-\ pain\\:\\ 0\\.015341064339664767\ \(0\)\
\-\ or\\:\\ 0\\.01491429359793339\ \(0\)\
